Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

IL-1β induces hypomyelination in the periventricular white matter through inhibition of oligodendrocyte progenitor cell maturation via FYN/MEK/ERK signaling pathway in septic neonatal rats.
Distinctive structural and functional MRI footprint for cognitive dysfunction in pediatric MS?
A palliative care hotline for multiple sclerosis: A pilot feasibility study.
Combined EPR and Molecular Modeling Study of PPI Dendrimers Interacting with Copper Ions: Effect of Generation and Maltose Decoration.
Safety and efficacy extension study of daclizumab high yield process (DAC HYP) to treat relapsing remitting multiple sclerosis
Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis.
The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis.
The diagnosis and management of lower urinary tract symptoms in multiple sclerosis patients.
No Regional Gray Matter Atrophy Differences between Pediatric- and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
Cannabinoid pharmacology: the first 66 years.
Inflammatory Response and Chemokine Expression in the White Matter Corpus Callosum and Gray Matter Cortex Region During Cuprizone-Induced Demyelination.
Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in sweden.
Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis.
Structural Insights from Binding Poses of CCR2 and CCR5 with Clinically Important Antagonists: A Combined In Silico Study.
Effect of Multiple Infusions of AIN457 on Disease Activity in Relapsing-remitting Multiple Sclerosis
The potential for new therapeutic approaches: Global research collaboration examines multiple pathways of neuroprotection in Huntington disease
Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.
Targeting Innate Receptors with MIS416 Reshapes Th Responses and Suppresses CNS Disease in a Mouse Model of Multiple Sclerosis.
[Posture disorders in patients with multiple sclerosis.]
Recent Gains in Clinical Multiple Sclerosis Research Review.
Preclinical retinal neurodegeneration in a model of multiple sclerosis.
A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
Eosinophilic Fasciitis Occurring under Treatment with Natalizumab for Multiple Sclerosis.
Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome.

Pages